4.8 Editorial Material

Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 383, Issue 10, Pages -

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMp2020076

Keywords

-

Funding

  1. National Institutes of Health

Ask authors/readers for more resources

Controlled human infection models have been proposed as a strategy for accelerating SARS-CoV-2 vaccine development. But scientific and technical factors make CHIMs unlikely to accelerate the establishment of vaccine efficacy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available